All systems operational
Q2 2014

Can serum tenascin-c be used as a marker of inflammation in patients with dilated cardiomyopathy?

Alyaa A. Kotby · Manal M. Abdel Aziz · Waleed M. El Guindy · Amira N. Moneer
10.1016/j.ehj.2013.12.009 383 Views 0 Citations
0
Citations
383
Views
Abstract not available for this publication.
Cite this Article (APA)
Alyaa, A. K., Manal, M. A. A., Waleed, M. E. G., Amira, N. M. (2014). Can serum tenascin-c be used as a marker of inflammation in patients with dilated cardiomyopathy?. The Egyptian Heart Journal. https://doi.org/10.1016/j.ehj.2013.12.009
Related Papers
C-reactive protein, inflammation and coronary heart disease
Amit Kumar Shrivastava; Harsh Vardhan Singh; Arun Raizada; Sanjeev Kumar Singh · 2015
248
cites
393
Incidence and predictors of post-catheterization femoral artery pseudoaneurysms
Hussein Heshmat Kassem; Mahmoud Farouk Elmahdy; Essam Baligh Ewis; Soilman Ghare · 2013
25
cites
393
13
cites
394
Access
View Full Text via DOI
Published in
ISSN 1110-2608
Quartile Q2
AMS Score 100
Field Medicine & Health Sciences
Publisher Springer Nature / SpringerOpen
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2014
Language English
Added 11 Aug 2026